tradingkey.logo

Cosmos Health Inc

COSM
View Detailed Chart
0.450USD
+0.010+2.23%
Close 02/06, 16:00ETQuotes delayed by 15 min
14.33MMarket Cap
LossP/E TTM

Cosmos Health Inc

0.450
+0.010+2.23%
Intraday
1m
30m
1h
D
W
M
D

Today

+2.23%

5 Days

-6.43%

1 Month

-16.37%

6 Months

-60.91%

Year to Date

-9.74%

1 Year

-37.79%

View Detailed Chart

TradingKey Stock Score of Cosmos Health Inc

Currency: USD Updated: 2026-02-06

Key Insights

Cosmos Health Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 120 out of 159 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 3.00.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Cosmos Health Inc's Score

Industry at a Glance

Industry Ranking
120 / 159
Overall Ranking
417 / 4521
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Cosmos Health Inc Highlights

StrengthsRisks
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Growing
The company is in a growing phase, with the latest annual income totaling USD 54.43M.
Undervalued
The company’s latest PE is -0.59, at a low 3-year percentile range.
Held by The Vanguard
Star Investor The Vanguard holds 235.74K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.15.

Analyst Rating

Based on 0 analysts
--
Current Rating
3.000
Target Price
+511.87%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Cosmos Health Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Cosmos Health Inc Info

Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Ticker SymbolCOSM
CompanyCosmos Health Inc
CEOSiokas (Grigorios)
Websitehttps://www.cosmosholdingsinc.com/
KeyAI